Quidel Corporation to Attend the Sixth Annual Craig-Hallum Institutional Investor Conference

SAN DIEGO--(Business Wire)--
Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care
diagnostic tests, today announced that it will attend the Sixth Annual
Craig-Hallum Institutional Investor Conference to be held at the Radisson Plaza
Hotel in Minneapolis, Minnesota on June 11, 2009.

Doug Bryant, president and chief executive officer, and John Radak, chief
financial officer, will participate in group and individual meetings with
institutional investors. To accommodate investors unable to attend the
conference the Company`s investor relations presentation will be available
beginning on June 11, 2009 at www.quidel.com under the "Presentations" section
found within the Investor Relations portion of the site.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well being of people around
the globe through the discovery, development, manufacturing and marketing of
rapid diagnostic solutions at the point of care (POC) in infectious diseases and
reproductive health. Marketed under the leading brand name of QuickVue, Quidel's
portfolio of products currently includes tests that aid in the diagnosis of
several disease or condition states, including influenza, respiratory syncytial
virus, Fecal Occult Blood, Strep A, pregnancy, bacterial vaginosis, H. pylori
and Chlamydia. Quidel's products are sold to healthcare professionals with a
focus on the physician office lab and acute care markets through leading medical
distribution partners on a worldwide basis. Quidel's Specialty Products Group
(SPG) develops research products in the fields of oncology and bone health with
potential future point-of-care applications. By building value in rapid
diagnostic tests, Quidel provides leadership to the industry and among
healthcare professionals allowing for the movement of patient testing out of the
central laboratory setting and into the physician office, urgent care and other
outpatient settings where rapid testing and treatment has an impact on clinical
outcomes and provides an economic benefit. For more information, visit
www.quidel.com, www.colorectal-test.com or www.flutest.com.

Quidel Corporation
John M. Radak, Chief Financial Officer, 858-646-8032
or
Porter Novelli Life Sciences
Parag Dave, 619-849-5378
pdave@pnlifesciences.com

Copyright Business Wire 2009